Molecule.one

Molecule.one is dedicated to developing an AI platform for drug synthesis. The company's machine learning system predicts the best way to synthesize potentially valuable molecules, a key part of creating new drugs and treatments. Our system has matured, and we have expanded our platform to support the synthesis planning of thousands of molecules per hour, using artificial intelligence to design new chemical compounds in seconds.